Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience - Top-Institutions - MDSpire

Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience

  • By

  • Jannis Krais

  • Matthias Lubnow

  • Alois Philipp

  • Maik Foltan

  • Florian Geismann

  • Christoph Fisser

  • Florian Hitzenbichler

  • Bernd Salzberger

  • Stilla Bauernfeind

  • Barbara Schmid

  • Dirk Lunz

  • Johannes Steinmann

  • Christoph Eissnert

  • Martin Kieninger

  • Walter Petermichl

  • Roland Schneckenpointner

  • Alexander Dietl

  • Lars S. Maier

  • Bernhard Graf

  • Thomas Müller

  • Clemens Wiest

  • July 15, 2026

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    University Hospital Regensburg
    University Hospital Regensburg

    Regensburg, Bavaria

    Key Differentiators

    • Pulmonology
    • Critical Care

  • #2

    Regensburg University Hospital
    Regensburg University Hospital

    Regensburg, Bavaria

    Key Differentiators

    • Pulmonology
    • Critical Care

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pulmonology
    • Critical Care

  • #4

    University of Barcelona
    University of Barcelona

    Barcelona, Catalonia

    Key Differentiators

    • Pulmonology
    • Critical Care

  • #5

    ASST Santi Paolo e Carlo
    ASST Santi Paolo e Carlo

    Milan, Lombardy

    Key Differentiators

    • Pulmonology
    • Infectious Diseases

Original Source(s)

Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience

  • by Jannis Krais, Matthias Lubnow, Alois Philipp, Maik Foltan, Florian Geismann, Christoph Fisser, Florian Hitzenbichler, Bernd Salzberger, Stilla Bauernfeind, Barbara Schmid, Dirk Lunz, Johannes Steinmann, Christoph Eissnert, Martin Kieninger, Walter Petermichl, Roland Schneckenpointner, Alexander Dietl, Lars S. Maier, Bernhard Graf, Thomas Müller, Clemens Wiest

  • July 15, 2026

Related Content

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization